HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. (Q45187803)
Jump to navigation
Jump to search
scientific article published in May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. |
scientific article published in May 2007 |
Statements
1 reference
HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. (English)
1 reference
Jonathan Shuter
1 reference
Julie A Sarlo
1 reference
Tina J Kanmaz
1 reference
Richard A Rode
1 reference
Barry S Zingman
1 reference
1 May 2007
1 reference
1 reference
Identifiers
1 reference